The epidermal growth factor receptor (EGFR) is one of the most important driver oncogenes in lung cancer, especially non-small cell lung cancer (NSCLC), which accounts for about 85% of lung cancer 2, 3. This evidence concerns the gene EGFR and lung cancer.